New Parameters Enable Eye Care Providers to Offer More Patients the Latest Advancements in Two-Week Contact Lens Technology
PLEASANTON, Calif., December 13, 2017 — CooperVision, Inc. has announced the nationwide availability of expanded parameters for its Avaira Vitality™ toric two-week contact lenses, which now include plus powers, high minus powers, and a -2.25D cylinder. The company has begun an initial rollout, and the full range will be available to all eye care professionals in the United States in January 2018.
“Through our partnerships with eye care providers, we have repeatedly heard that there is still a place for two-week contact lenses in today’s practices,” said Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision. “Now, practices across the United States will have access to all parameters of Avaira Vitality™ toric, making the latest advancements in two-week contact lens technology available to an even greater number of astigmatic wearers. CooperVision continues to offer the broadest, most comprehensive contact lens portfolio in the industry.”
Made from a new silicone hydrogel material (fanfilcon A), Avaira Vitality™ toric delivers the best of Avaira® toric with a higher water content (55%) and high level of oxygen permeability and transmissibility, resulting in a healthier lens-wearing experience.* UV protection has also been improved to Class I—the top rating—which means the lenses now block more than 90 percent of UVA and 99 percent of UVB rays.**
Avaira Vitality™ toric maintains CooperVision’s unique Optimized Toric Lens Geometry™, which helps to provide the same consistent visual acuity that eye care professionals and their patients have appreciated in Avaira® toric, ensuring an easy refit. A uniform horizontal ISO thickness improves lens stability and reduces rotation and a large toric optic zone provides clear visual acuity. An optimized ballast toric design provides a stable, comfortable fit, while its smooth, continuous ballast maximizes comfort during eye lid interaction.
“The ease of fit and stability of vision, combined with exceptional patient comfort and office profitability has made Avaira Vitality™ toric a winner for my patients and my practice,” said John C. Zelazowski, OD, who owns Alle-Kiski Eye Care in Cheswick, Pa.
With the expansion to the full range, Avaira Vitality™ toric is available in a power range of +8.00D to -10.00D with cylinder options of -0.75D, -1.25D, -1.75D, and -2.25D in axes from 10° to 180° in 10° steps. They have a modulus of 0.6MPa, a DK of 90, and a Dk/t of 90. The base curve is 8.5mm and the diameter is 14.5mm.
A recent study comparing Avaira Vitality™ toric contact lenses with ACUVUE® OASYS® FOR ASTIGMATISM lenses found Avaira Vitality™ toric was preferred 3 to 1 by patients for overall performance.1 Avaira Vitality™ was rated significantly higher for comfort,1 vision quality1 and less dryness.1,2
For more information, visit www.coopervision.com/contact-lenses/avaira-vitality.
* With higher oxygen permeability than hydrogel materials, silicone hydrogel contact lenses minimize or eliminate hypoxia-related signs and symptoms during lens wear.
** Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
1. Results from a randomized, bilateral, double-masked, 2-week cross-over, 23 subject, daily wear dispensing study comparing Avaira VitalityTM toric lenses with ACUVUE® OASYS® FOR ASTIGMATISM lenses. Rating scale (0 to 10).
2. Rating for less end-of-day dryness.
# # #
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Heather Kowalczyk, APR
McDougall Communications for CooperVision
email@example.com or (585) 330-4878